The second volume has been published in the Longevity Industry Landscape Overview compendium. The various authors and funding organizations aim to survey all of the participants in the present scientific and business communities focused on the treatment of aging as a medical condition. The focus is on breadth of coverage rather than depth, so this is another sizable document. Once past the introductory sections, most of it is useful for reference rather than reading. But you should still take a look at those opening chapters.
“The majority of politicians and the general public are unaware of the tremendous potential benefits of regenerative medicine. They fail to grasp the profound implications that extended longevity could have on the global economy, on their respective nation’s economic survival, and on their own lifespan and health.” When did geroscience become a science? When did longevity become an industry? When did it become a ‘business’? For almost all of recorded history, it has been a fantasy. During the first half of the 20th century, healthy life extension meant either devising specialised techniques for treating specific diseases or nursing and elderly care. This remained the case throughout both the scientific and industrial revolutions,
Article originally posted at